NCT00480597View on ClinicalTrials.gov

Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

October 31, 2002

Conditions
Metastatic Breast Cancer
Interventions
DRUG

gemcitabine

DRUG

cisplatin

DRUG

vinorelbine

DRUG

capecitabine

All Listed Sponsors
lead

Ludwig-Maximilians - University of Munich

OTHER

NCT00480597 - Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter